Ivax Launches Neurontin Generic As User Fee Date For Pfizer's Pregabalin Nears

Non-AB-rated gabapentin tablets launch "at risk" less than two weeks before the estimated Aug. 30 user fee deadline for Pfizer's follow-on drug Lyrica. Pfizer is seeking a temporary restraining order against Ivax.